
Paul Romesser, MD
Radiation Oncologist
Titles
Assistant Attending Radiation Oncologist
Clinical Expertise
Gastrointestinal Cancers; Rectal Cancer; Anal Cancer; Pancreas Cancer; Liver Cancer; Breast Cancer; Image-guided radiation therapy (IGRT); Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Radiosurgery (SRS); Proton Beam Radiotherapy (PBRT)
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Romesser accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-888- 2118 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Boston University School of Medicine
Residencies
Radiation Oncology - Memorial Sloan Kettering Cancer Center
I am a board-certified radiation oncologist who has expertise in using advanced techniques to treat cancer. These include image-guided radiation therapy, intensity-modulated radiation therapy, stereotactic radiosurgery, and proton beam radiotherapy. I am also actively involved in cancer clinical trials. I work to take ideas developed in the lab and translate them into actual trials and treatments that can benefit people with cancer. I am a member of the NRG Oncology colorectal and non-colorectal gastrointestinal cancer committees and the National Cancer Institute’s Rectal-Anal Task Force. My work has been published in Nature, Science, Lancet Oncology, Clinical Cancer Research, International Journal of Radiation Oncology and Biophysics, and Cancer.
Read more
At Memorial Sloan Kettering, we approach treating cancer as a team. I work closely with surgical and medical oncologists, radiologists, and pathologists. I can confidently tell my patients that they will receive the best care in the world because of the team of experts that will support them every step of the way. I make sure all my patients are aware of who is on their care team, our individual roles, and how we work together to create a personalized treatment plan.
I also make sure my patients have a solid understanding of their diagnosis. I take time to explain how radiation therapy fits into treating their disease, as well as all the potential benefits and side effects. While many patients have concerns about radiation therapy, I hope that after meeting with me, they and their families feel reassured about what lies ahead.
Clinical trials, in my opinion, offer patients an opportunity to get the most progressive cancer care available. I know that the decision to participate or not participate in a trial can make people anxious. Ultimately the decision is a very personal one for patients and their families. I hope that by explaining the ins and outs of clinical trials, I can help guide my patients to make the right decision for them.
After patients leave my office, I hope that they feel that they have a strong advocate who will stop at nothing to ensure they are getting the best treatment.
I can confidently tell my patients that they will receive the best care in the world because of the team of experts that will support them every step of the way.
-Dr. Romesser
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all External Beam Radiotherapy Service, Manhattan doctors
See all Brachytherapy Service doctors
Clinical Trials
- Clinical Trials Investigated by Dr. Romesser
- A Phase I Study of XRD-0394 in People with Cancer Who Are Receiving Palliative Radiation Therapy
- A Phase II Study Evaluating the Effectiveness of a Lower Dose of Chemoradiation to Treat Early-Stage Anal Cancer
- A Phase II Study of Targeted Radiation Therapy for People with Non-Small Cell Lung Cancer that Spread to the Liver
- Clinical Trials Co-Investigated by Dr. Romesser
- A Phase II Study Assessing the Addition of Irinotecan to Combination Chemotherapy after Chemoradiation in Patients with Stage II or III Rectal Cancer to Improve the Rate of Complete Response
Read more
- A Phase II Study of Proton versus Photon Beam Radiotherapy to Treat Head and Neck Cancer
- A Phase II Study of Tucatinib and Trastuzumab Followed by Chemotherapy as Initial Treatment for Locally Advanced HER2-Positive Rectal Cancer
- A Study Assessing the Effects of Chemotherapy or Radiation Therapy on Reproductive and Sexual Health in People with Early-Onset Colorectal Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Romesser PB, Cahlon O, Scher E, Zhou Y, Berry SL, Rybkin A, Sine KM, Tang S, Sherman EJ, Wong R, Lee NY. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiotherapy and Oncology. 2016; 118(2):286-292. PMID 26867969.
Read more
Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, DeSelm C, Fox, JL, Mah D, Garg, MK, Chang J, Lee NY. Proton beam re-irradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes. International Journal of Radiation Oncology Biology, and Physics. 2016; 95(1):386-395. PMID: 27084656.
Romesser PB, Romanyshyn JC, Schupak KD, Setton J, Riaz N, Wolden SL, Gelblum DY, Sherman EJ, Kraus D, Lee NY. Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy. Cancer. 2012; 118(24):6072-6078. PMID 22707358.
Romesser PB, Sherman EJ, Shaha AR, Lian M, Wong RJ, Sabra M, Rao SS, Fagin JA, Tuttle RM, Lee NY. External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer. Journal of Surgical Oncology. 2014; 110(4):375-382. PMID 24961938.
Romesser PB, Lim R, Spratt DE, Setton J, Riaz N, Lok B, Sherman EJ, Schoder H, Lee NY. The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pretreatment 18F-fluorodeoxyglucose positron emission tomography scan. Oral Oncology. 2014; 50(9):802-808. PMID 25043882.
Visit PubMed for a full listing of Dr. Romesser’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Paul Romesser discloses the following relationships and financial interests:
-
EMD Serono, Inc
Provision of Services (uncompensated) -
HPV Alliance
Provision of Services (uncompensated)
-
HPV and Anal Cancer Foundation
Provision of Services (uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].